06 Aug

SEC – BATS Deal Sign Of White's Plan In Action

The Securities and Exchange Commission (SEC) is in negotiations with BATS Global Markets, Inc. (BATS:BATS) to settle charges the stock exchange provided high frequency traders unfair advantages, the Wall Street Journal is reporting, citing unnamed sources. The move could the the first major manifestation from SEC Charwoman Mary Jo White's plan to reign in the trading practice.

exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Related Posts

19 Apr

Abenomics Breathes New Life In Japan Focused Hedge Funds

By

Abenomics has been working well for a considerable number of hedge funds with short yen and long Japanese equity positions. Shinzo Abe's no holds barred fiscal easing policy has... read more

Multi-Factor Design
04 Feb

Rate My Investor Seeks To Turn The Tables On Venture Capital Funding

By

Serial entrepreneur Austin Stofer has the battle scars that can come from being squeezed and stretched through what can seem like a venture capital torture chamber. He knows first-hand... read more

12 Aug

Albert Edwards Says Yuan Devaluation Was "Inevitable"

By

Chinese devaluation of the renminbi was expected in certain quarters – and it is just the start, says a leading bank analyst, as he eyes an endgame that points... read more

27 Sep

With US Stock Market Breaking Into New Highs, Top Hedge Fund Performers Focused Abroad

By

With the US stock market breaking into new highs in September, the HSBC Hedge Weekly performance list continues to have a distinctly Chinese flavor to it. Of the top... read more

Tesla stock
24 Nov

Is Tesla Motors Inc Really Under Investigation By The SEC?

By

Tesla Motors Inc (NASDAQ:TSLA) may have an undisclosed investigation open with the Securities and Exchange Commission, according to Probes Reporter. However, analysts who are bullish on the automaker classify... read more

17 Jul

International Business Machines Corp. (IBM) Q2 Earnings Preview

By

The technology giant delivered disappointing earnings last quarter and recently started cutting staff. Will Q2, 2013 be any better for CEO Ginni Rometty and the IBM team? The answer... read more

Too Big To Default Big Banks Default Rights
24 Feb

Break Up The Big Banks? Seven Reasons Why That's A Bad Idea

By

Break Up The Big Banks? Seven Reasons Why That's A Bad Idea In recent months, many politicians and policymakers have grown more aggressively vocal in their call to break up... read more

US sector returns
27 Jun

U.S. Technology Sector – Is The Sun Setting?

By

Using their internal model, analysts at Source believe the US Technology sector is overvalued, while they move in the opposite direction on the European Technology sector by upgrading it to... read more

dollar strength
14 Dec

Albert Edwards On The “Dog That Isn’t Barking”

By

What makes Albert Edwards popular is his ability to intelligently question mainstream consensus drool, look where others don’t look, and do so in an entertaining fashion.  The Societie Generale... read more

17 Nov

Generic Drug Producers Have $45 Billion Opportunity

By

Generic drug producers have been handed windfall sales over the past decade. According to a new report from Morgan Stanley on the state of the generic drug industry published... read more

Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 10/31/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others

 

0